Abstract
Clonidine and cirazoline bind with high affinity to a nonadrenergic site in the brain stem, the so-called imidazoline I1 receptor. Our aim was to determine the mechanism by which these receptors act and their possible linkage to signal-transducing heterotrimeric G-proteins. We examined the effects of clonidine and cirazoline on PC-12 cells, a neuronal cell line that is reported to possess the I1 site and have no alpha 2-adrenoceptors. In undifferentiated PC-12 cells loaded with the Ca2+ indicator dye fura-2, clonidine and cirazoline (10-100 microM) inhibited the increase in [Ca2+]i produced by nicotine (10 microM). This inhibition was not reversed by yohimbine (100 microM), and adrenaline and BHT 920 were ineffective at 100 microM. This effect was not inhibited by pretreatment with pertussis toxin (24 hours, 100 ng/ml) and not modulated by pretreatment with IBMX (100 microM). The nicotine-induced increase in [Ca2+]i is apparently due to Ca2+ entering via the intrinsic ion channel of the nicotinic acetylcholine receptor. Clonidine and cirazoline inhibited the inward current produced by nicotine (10 microM) as measured by the whole cell patch-clamp technique in differentiated PC-12 cells, recorded at a holding potential of -60 mV...Continue Reading
References
Apr 3, 1979·Biochemistry·P R Hartig, M A Raftery
Apr 1, 1978·European Journal of Biochemistry·W Schiebler, F Hucho
Jul 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·L A Greene, A S Tischler
Jan 1, 1992·Fundamental & Clinical Pharmacology·P BousquetE Tibiriça
Jun 1, 1992·Cellular and Molecular Neurobiology·M Ohara-Imaizumi, K Kumakura
Feb 1, 1992·Biochemical Society Transactions·A T KilpatrickA C Mackinnon
Apr 1, 1992·American Journal of Hypertension·D J ReisM P Meeley
Jun 1, 1992·Current Opinion in Neurobiology·L W Role
Jun 1, 1991·Biochemical Pharmacology·D Atlas
Jan 25, 1991·European Journal of Pharmacology·V Lachaud-PettitiA Parini
Dec 1, 1991·Naunyn-Schmiedeberg's Archives of Pharmacology·G J MolderingsM Göthert
Mar 1, 1991·Naunyn-Schmiedeberg's Archives of Pharmacology·M Göthert, G J Molderings
Dec 17, 1991·European Journal of Pharmacology·E TibiriçaP Bousquet
Sep 1, 1989·Trends in Pharmacological Sciences·M C Michel, P A Insel
Oct 1, 1988·The Biochemical Journal·G Milligan
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
Jul 15, 1994·The Biochemical Journal·I F MusgraveG Schultz
Jun 1, 1993·Journal of Neurochemistry·C K Min, G A Weiland
Jun 1, 1993·Current Opinion in Neurobiology·A Karlin
Jul 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·G J MolderingsM Göthert
Feb 1, 1993·Neurochemistry International·G BriccaP Bousquet
Citations
Aug 29, 1996·European Journal of Pharmacology·G OlmosJ A García-Sevilla
Apr 4, 1997·European Journal of Pharmacology·S L ChanN G Morgan
Sep 7, 2000·Neuropharmacology·D MilhaudM Lafon-Cazal
Dec 16, 1998·Journal of the Autonomic Nervous System·G A HeadI F Musgrave
Dec 16, 1998·Journal of the Autonomic Nervous System·I F Musgrave, R A Hughes
Jul 28, 2001·Autonomic Neuroscience : Basic & Clinical·M TakedaJ Lipski
Aug 24, 1999·British Journal of Pharmacology·G OlmosJ A García-Sevilla
Oct 1, 1996·Clinical and Experimental Pharmacology & Physiology·R G Evans
Oct 1, 1996·Clinical and Experimental Pharmacology & Physiology·I F MusgraveG Schultz
Jul 23, 1999·Annals of the New York Academy of Sciences·I F Musgrave, R A Hughes
Feb 11, 1999·Anesthesia and Analgesia·K NishinaY Niwa
Nov 9, 2001·Japanese Journal of Pharmacology·S ChungT Nam
Feb 27, 2003·The Journal of Pharmacology and Experimental Therapeutics·Walter RaaschPeter Dominiak
Dec 11, 2019·Pharmacological Reviews·Pascal BousquetJun-Xu Li
Jul 12, 1995·Annals of the New York Academy of Sciences·G J MolderingsM Göthert
Dec 31, 1997·The American Journal of Physiology·D J Reis, J E Piletz